Search

Search Constraints

You searched for: Author/Creator Frequin, Stephan

Search Results

1. Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS. Issue 5 (15th November 2017)

2. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

3. A Dutch validation study of the Multiple Sclerosis Work Difficulties Questionnaire in relapsing remitting multiple sclerosis. Issue 13 (19th June 2021)